Search: onr:"swepub:oai:DiVA.org:uu-403393" >
Patients With Atria...
-
Dalgaard, FrederikHerlev & Gentofte Hosp, Dept Cardiol, Hellerup, Denmark;Duke Univ, Duke Clin Res Inst, Durham, NC USA
(author)
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial
- Article/chapterEnglish2020
Publisher, publication year, extent ...
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-403393
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-403393URI
-
https://doi.org/10.1161/CIRCULATIONAHA.119.041296DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Background:The use of nonsteroidal anti-inflammatory drugs (NSAIDs) with oral anticoagulants has been associated with an increased risk of bleeding. We investigated the risk of bleeding and major cardiovascular outcomes in patients with atrial fibrillation taking NSAIDs and apixaban or warfarin.Methods:The ARISTOTLE trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; n=18 201) compared apixaban with warfarin in patients with atrial fibrillation at an increased risk of stroke. Patients in ARISTOTLE without severe renal (creatine clearance ≤30 mL/min) or liver disease were included in this analysis (n=17 423). NSAID use at baseline, NSAID use during the trial (incident NSAID use), and never users were described. The primary outcome was major bleeding. Secondary outcomes included clinically relevant nonmajor bleeding, gastrointestinal bleeding, heart failure hospitalization, stroke or systemic embolism, and all-cause mortality. NSAID use during the trial, and the interaction between randomized treatment, was analyzed using time-dependent Cox proportional hazards models.Results:Those with baseline NSAID use (n=832 [4.8%]), incident NSAID use (n=2185 [13.2%]), and never users were similar in median age (age [25th, 75th]; 70 [64, 77] versus 70 [63, 75] versus 70 [62, 76]). Those with NSAID use at baseline and incident NSAID use were more likely to have a history of bleeding than never users (24.5% versus 21.0% versus 15.6%, respectively). During a median follow-up (25th, 75th) of 1.8 (1.4, 2.3) years and when excluding those taking NSAID at baseline, we found that incident NSAID use was associated with an increased risk of major bleeding (hazard ratio [HR], 1.61 [95% CI, 1.11–2.33]) and clinically relevant nonmajor bleeding (HR, 1.70 [95% CI, 1.16–2.48]), but not gastrointestinal bleeding. No significant interaction was observed between NSAID use and randomized treatment for any outcome.Conclusions:A substantial number of patients in the ARISTOTLE trial took NSAIDs. Incident NSAID use was associated with major and clinically relevant nonmajor bleeding, but not with gastrointestinal bleeding. The safety and efficacy of apixaban versus warfarin appeared not significantly to be altered by NSAID use. This study warrants more investigation of the effect of NSAIDs on the outcomes of patients treated with apixaban.Clinical Trial Registration:URL: https://www.clinicaltrials.gov. Unique identifier: NCT00412984.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Mulder, HillaryDuke Univ, Duke Clin Res Inst, Durham, NC USA
(author)
-
Wojdyla, Daniel M.Duke Univ, Duke Clin Res Inst, Durham, NC USA
(author)
-
Lopes, Renato D.Duke Univ, Duke Clin Res Inst, Durham, NC USA
(author)
-
Held, Claes,1956-Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi(Swepub:uu)clahe947
(author)
-
Alexander, John H.Duke Univ, Duke Clin Res Inst, Durham, NC USA
(author)
-
De Caterina, RaffaeleUniv Pisa, Inst Cardiol, Pisa, Italy
(author)
-
Washam, Jeffrey B.Duke Univ, Duke Clin Res Inst, Durham, NC USA
(author)
-
Hylek, Elaine M.Boston Univ, Sch Med, Boston, MA 02215 USA
(author)
-
Garcia, David A.Univ Washington, Sch Med, Seattle, WA USA
(author)
-
Gersh, Bernard J.Mayo Clin, Coll Med, Rochester, MN USA
(author)
-
Wallentin, Lars,1943-Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)larswall
(author)
-
Granger, Christopher B.Duke Univ, Duke Clin Res Inst, Durham, NC USA
(author)
-
Al-Khatib, Sana M.Duke Univ, Duke Clin Res Inst, Durham, NC USA
(author)
-
Herlev & Gentofte Hosp, Dept Cardiol, Hellerup, Denmark;Duke Univ, Duke Clin Res Inst, Durham, NC USADuke Univ, Duke Clin Res Inst, Durham, NC USA
(creator_code:org_t)
Related titles
-
In:Circulation141:1, s. 10-200009-73221524-4539
Internet link
Find in a library
To the university's database
- By the author/editor
-
Dalgaard, Freder ...
-
Mulder, Hillary
-
Wojdyla, Daniel ...
-
Lopes, Renato D.
-
Held, Claes, 195 ...
-
Alexander, John ...
-
show more...
-
De Caterina, Raf ...
-
Washam, Jeffrey ...
-
Hylek, Elaine M.
-
Garcia, David A.
-
Gersh, Bernard J ...
-
Wallentin, Lars, ...
-
Granger, Christo ...
-
Al-Khatib, Sana ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cardiac and Card ...
- Articles in the publication
-
Circulation
- By the university
-
Uppsala University